China's perspective on similar biotherapeutic products

Biologicals

Volumn 39, Issue 5, 2011, Pages 312-316

  Liang, Chenggang ^a   Wang, Junzhi ^a  

^a NATIONAL INSTITUTES FOR FOOD AND DRUG CONTROL   (China)

Author keywords

Drug regulation; Non innovator product; Similar biotherapeutic products (SBPs)

Indexed keywords

BIOLOGICAL PRODUCT; HUMAN GROWTH HORMONE; RECOMBINANT FOLLITROPIN;

ARTICLE; CHINA; DEVELOPING COUNTRY; DRUG APPROVAL; DRUG COST; DRUG EFFICACY; DRUG MANUFACTURE; DRUG MARKETING; DRUG QUALITY; DRUG RESEARCH; DRUG SAFETY; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; LOWEST INCOME GROUP; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; TECHNOLOGY; WORLD HEALTH ORGANIZATION;

CHINA; DRUG APPROVAL; DRUG INDUSTRY; GUIDELINES AS TOPIC; HUMANS; LEGISLATION, DRUG; PHARMACEUTICAL PREPARATIONS; QUALITY CONTROL;

EID: 80053572229     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2011.06.020     Document Type: Article

References (0)